Culley Brian M

CIK 00013106832 companiesCARLSBAD, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001310683

Recent Transactions

25 trades

Tax Payment
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares
2025-12-19$1.68/sh−334→ 222,135 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares
2025-12-19+8,925→ 222,469 total
Purchase
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares
2024-05-24$1.05/sh+10,000→ 154,842 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Employee Stock Option (Right to Buy)
2024-03-07+1,900,000→ 1,900,000 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2024-02-11+31,249→ 157,648 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Restricted Stock Units
2024-02-11−31,249→ 62,499 total
Tax Payment
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2024-02-11$1.08/sh−12,806→ 144,842 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Restricted Stock Units
2023-02-11−31,249→ 93,748 total
Tax Payment
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2023-02-11$1.35/sh−12,744→ 126,399 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2023-02-11+31,249→ 139,143 total
Tax Payment
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2021-12-31$2.45/sh−5,343→ 76,030 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Restricted Stock Units
2021-12-31−15,450→ 30,900 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2021-12-31+15,450→ 81,373 total
Tax Payment
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2021-09-30$2.52/sh−5,343→ 65,923 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2021-09-30+15,450→ 71,266 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Restricted Stock Units
2021-09-30−15,450→ 46,350 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Employee Stock Option (Right to Buy)
2021-03-15+1,165,100→ 1,165,100 total
Tax Payment
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2020-12-31$1.76/sh−5,343→ 185,602 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Restricted Stock Units
2020-12-31−15,450→ 92,700 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2020-12-31$1.76/sh+15,450→ 190,945 total
Award
Savara Inc$SVRA
Employee Stock Option (Right to Buy)
2016-01-04+1,227,100→ 1,227,100 total
Award
Savara Inc$SVRA
Stock Option (Right to Buy)
2015-01-02+2,100,550→ 2,100,550 total
Award
Savara Inc$SVRA
Employee Stock Option (Right to Buy)
2014-01-02+650,300→ 650,300 total
Sale
Savara Inc$SVRA
COMMON STOCK
2011-06-02$2.44/sh−5,000→ 0 total
Award
Savara Inc$SVRA
Stock Option (Right to Buy)
2007-01-12+150,000→ 150,000 total

Companies

Recent Filings

Address

2173 SALK AVENUE, SUITE 200

CARLSBAD, CA, 92008

View on SEC.gov